Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	210
Overall Study	STARTED	AVP-786-28	151
Overall Study	STARTED	AVP-786-42.63	161
Overall Study	Safety Population	Placebo	210
Overall Study	Safety Population	AVP-786-28	151
Overall Study	Safety Population	AVP-786-42.63	160
Overall Study	Modified Intent-to-Treat (mITT) Population	Placebo	210
Overall Study	Modified Intent-to-Treat (mITT) Population	AVP-786-28	150
Overall Study	Modified Intent-to-Treat (mITT) Population	AVP-786-42.63	159
Overall Study	COMPLETED	Placebo	192
Overall Study	COMPLETED	AVP-786-28	121
Overall Study	COMPLETED	AVP-786-42.63	146
Overall Study	NOT COMPLETED	Placebo	18
Overall Study	NOT COMPLETED	AVP-786-28	30
Overall Study	NOT COMPLETED	AVP-786-42.63	15

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02442778/flow